Biodegradable microparticles as oral vaccines.
O'Hagan
D T
DT
Department of Pharmaceutical Sciences, University of Nottingham, United Kingdom.
Jeffery
H
H
Maloy
K J
KJ
Mowat
A M
AM
Rahman
D
D
Challacombe
S J
SJ
D000284:Administration, Oral; D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001672:Biocompatible Materials; D001673:Biodegradation, Environmental; D002214:Capsules; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems; D018928:Immunity, Mucosal; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000096:biosynthesis / Q000097:blood; D019344:Lactic Acid; D051379:Mice; D008807:Mice, Inbred BALB C; D010047:Ovalbumin / Q000008:administration & dosage / Q000276:immunology; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers / Q000008:administration & dosage; D012463:Saliva / Q000276:immunology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage*
D000941:Antigens; D001672:Biocompatible Materials; D002214:Capsules; D003692:Delayed-Action Preparations; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D011108:Polymers; D014612:Vaccines; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D010047:Ovalbumin